Requires health insurers to cover self-measured blood pressure monitoring for subscribers with preeclampsia; requires health care professionals to provide home blood pressure monitor to pregnant patients diagnosed with preeclampsia.

This New Jersey bill (A 2200) mandates that health insurers cover home blood pressure monitoring for pregnant patients diagnosed with preeclampsia. It requires insurers to provide validated home blood pressure monitors and reimburse healthcare providers for training patients on device use, data transmission, and interpretation. The law directly affects pregnant individuals in New Jersey with preeclampsia and all health insurers offering coverage in the state. Key provisions define "validated monitors" as devices listed in the U.S. Blood Pressure Validated Device Listing and specify that this coverage must be provided at the same level as other medical conditions. The bill aims to improve maternal outcomes by ensuring access to home monitoring for a condition affecting 5-8% of pregnant New Jersey women annually.